Terms: = Thyroid cancer AND CBFB, PEBP2B, 865, ENSG00000067955, Q13951 AND Prognosis
6 results:
1. Construction of a risk stratification model integrating ctDNA to predict response and survival in neoadjuvant-treated breast cancer.
Liu Z; Yu B; Su M; Yuan C; Liu C; Wang X; Song X; Li C; Wang F; Ma J; Wu M; Chen D; Yu J; Yu Z
BMC Med; 2023 Dec; 21(1):493. PubMed ID: 38087296
[TBL] [Abstract] [Full Text] [Related]
2. Evaluation of plasma exosomal miRNAs as potential diagnostic biomarkers of lymph node metastasis in papillary thyroid carcinoma.
Chen W; Li G; Li Z; Zhu J; Wei T; Lei J
Endocrine; 2022 Mar; 75(3):846-855. PubMed ID: 34854020
[TBL] [Abstract] [Full Text] [Related]
3. Risk Factors of Metastatic Lymph Nodes in Papillary thyroid Microcarcinoma.
Ruiz Pardo J; Ríos A; Rodríguez JM; Paredes M; Soriano V; Oviedo MI; Hernández AM; Parrilla P
Cir Esp (Engl Ed); 2020 Apr; 98(4):219-225. PubMed ID: 31980154
[TBL] [Abstract] [Full Text] [Related]
4. Incidental versus clinical diagnosis of papillary thyroid microcarcinoma. Long-term prognosis.
Ruiz J; Ríos A; Rodríguez JM; Paredes M; Soriano V; Oviedo MI; Hernández AM; Parrilla P
Endocrinol Diabetes Nutr (Engl Ed); 2020 May; 67(5):317-325. PubMed ID: 31882257
[TBL] [Abstract] [Full Text] [Related]
5. Locally advanced epithelial sinonasal tumors: The impact of multimodal approach.
Orlandi E; Cavalieri S; Granata R; Nicolai P; Castelnuovo P; Piazza C; Schreiber A; Turri-Zanoni M; Quattrone P; Miceli R; Infante G; Sessa F; Facco C; Calareso G; Iacovelli NA; Mattavelli D; Paderno A; Resteghini C; Locati LD; Licitra L; Bossi P
Laryngoscope; 2020 Apr; 130(4):857-865. PubMed ID: 31369156
[TBL] [Abstract] [Full Text] [Related]
6. Outcome of the Diffuse Sclerosing Variant of Papillary thyroid cancer: A Meta-Analysis.
Malandrino P; Russo M; Regalbuto C; Pellegriti G; Moleti M; Caff A; Squatrito S; Vigneri R
Thyroid; 2016 Sep; 26(9):1285-92. PubMed ID: 27349273
[TBL] [Abstract] [Full Text] [Related]
